Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
AI disclosure
Summary
Eli Lilly and Regeneron are among the first seven companies the FDA has selected for its PreCheck Pilot Program, CNBC has learned.